In clinical studies, it has been shown that estrogen replacement therapy in menopause is strongly correlated with a reduced risk of the development of Alzheimer's disease (AD). In in vitro experiments, it was demonstrated that estradiol protects cells against the toxic effects of -amyloid, the majo
Metal swap between Zn7-metallothionein-3 and amyloid-β–Cu protects against amyloid-β toxicity
✍ Scribed by Meloni, Gabriele; Sonois, Vanessa; Delaine, Tamara; Guilloreau, Luc; Gillet, Audrey; Teissié, Justin; Faller, Peter; Vašák, Milan
- Book ID
- 109913541
- Publisher
- Nature Publishing Group
- Year
- 2008
- Tongue
- English
- Weight
- 325 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1552-4450
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In this DFT study, a mechanism of the oxidation of methionine (Met) amino acid residue catalyzed by the metal (Cu^2+^, Zn^2+^, and Fe^3+^) bound amyloid beta (Aβ) peptide has been proposed. Based on experimental information, two different mechanisms: (1) stepwise and (2) concerted mecha
## Abstract Amyloid‐β peptide (Aβ) has been implicated in the etiopathogenesis of Alzheimer's disease (AD). However, the molecular mechanisms underlying Aβ neurotoxicity remain to be elucidated. This study showed that Aβ treatment resulted in the increased phosphorylation (activation) of MLK3, MKK7